Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Maison

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
The Lancet. Neurology|March 21, 2006
Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up studyAnne-Catherine Bachoud-Lévi, Véronique Gaura, Pierre Brugières, et al.
Plos One|May 27, 2015
Longitudinal study of informed consent in innovative therapy research: experience and provisional recommendations from a multicenter trial of intracerebral graftingLaurent Cleret de Langavant, Sophie Sudraud, Christophe Verny, et al.
Plos One|September 15, 2016
Insulin-Like Growth Factor-1 but Not Insulin Predicts Cognitive Decline in Huntington's DiseaseLinda Salem, Nadine Saleh, Gaelle Désaméricq, et al.
Frontiers in Public Health|December 4, 2023
Prevention and management of health products shortages by the French national agency (ANSM), 10 years of experienceLaëtitia Belgodère, Joseph Emmerich, Nicolas Albin, et al.
Plos One|January 24, 2014
Effectiveness of anti-psychotics and related drugs in the Huntington French-speaking group cohortGaëlle Désaméricq, Guillaume Dolbeau, Christophe Verny, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 25, 2017
A randomized, double-blind, placebo-controlled trial evaluating cysteamine in Huntington's diseaseChristophe Verny, Anne-Catherine Bachoud-Lévi, Alexandra Durr, et al.
Plos One|September 23, 2016
COMT Val158Met Polymorphism Modulates Huntington's Disease ProgressionRuth de Diego-Balaguer, Catherine Schramm, Isabelle Rebeix, et al.
Neurobiology of Disease|July 14, 2009
A genetic variation in the ADORA2A gene modifies age at onset in Huntington's diseaseClaire-Marie Dhaenens, Sylvie Burnouf, Clémence Simonin, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
The Lancet. Neurology|March 21, 2006
Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up studyAnne-Catherine Bachoud-Lévi, Véronique Gaura, Pierre Brugières, et al.
Plos One|May 27, 2015
Longitudinal study of informed consent in innovative therapy research: experience and provisional recommendations from a multicenter trial of intracerebral graftingLaurent Cleret de Langavant, Sophie Sudraud, Christophe Verny, et al.
Plos One|September 15, 2016
Insulin-Like Growth Factor-1 but Not Insulin Predicts Cognitive Decline in Huntington's DiseaseLinda Salem, Nadine Saleh, Gaelle Désaméricq, et al.
Frontiers in Public Health|December 4, 2023
Prevention and management of health products shortages by the French national agency (ANSM), 10 years of experienceLaëtitia Belgodère, Joseph Emmerich, Nicolas Albin, et al.
Plos One|January 24, 2014
Effectiveness of anti-psychotics and related drugs in the Huntington French-speaking group cohortGaëlle Désaméricq, Guillaume Dolbeau, Christophe Verny, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 25, 2017
A randomized, double-blind, placebo-controlled trial evaluating cysteamine in Huntington's diseaseChristophe Verny, Anne-Catherine Bachoud-Lévi, Alexandra Durr, et al.
Plos One|September 23, 2016
COMT Val158Met Polymorphism Modulates Huntington's Disease ProgressionRuth de Diego-Balaguer, Catherine Schramm, Isabelle Rebeix, et al.
Neurobiology of Disease|July 14, 2009
A genetic variation in the ADORA2A gene modifies age at onset in Huntington's diseaseClaire-Marie Dhaenens, Sylvie Burnouf, Clémence Simonin, et al.
Pageof 9